US Patent Issued to Sun Pharmaceutical Industries on March 11 for "Crystalline form of deuruxolitinib phosphate" (Massachusetts Inventor)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,034, issued on March 11, was assigned to Sun Pharmaceutical Industries Inc. (Princeton, N.J.).

"Crystalline form of deuruxolitinib phosphate" was invented by Sean Wiedemann (Burlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to polymorph Form 1 of 1H-pyrazole-1-propanenitrile, Beta-(cyclopentyl-2,2,3,3,4,4,5,5-d8)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (BetaR)-, phosphate (1:1) (deuruxolitinib phosphate). Also disclosed are methods of treatment using polymorph Form 1 of deuruxolitinib phosphate and methods of making polymorph Form 1 of deuruxolitinib phosphate."

The patent was filed on May 10, 2024, ...